A Phase II Study of Intermittent Duvelisib Dosing in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

被引：0
|
作者：
Shouse, Geoffrey P. [1 ]
Chen, Lu [2 ]
Siddiqi, Tanya [3 ]
Muir, Alex [4 ]
Brown, Jennifer R. [5 ]
Spurgeon, Stephen E. [6 ]
Danilov, Alexey [7 ]
机构：
[1] City Hope Natl Med Ctr, Hematol HCT, Duarte, CA USA
[2] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, Duarte, CA USA
[3] City Hope Natl Med Ctr, Irvine, CA USA
[4] City Hope Natl Med Ctr, Duarte, CA USA
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[6] Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Hematol Malignancies, Portland, OR USA
[7] City Hope Natl Med Ctr, Dept Hematol & HCT, La Canada Flintridge, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182543
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma
    J A Woyach
    T S Lin
    M S Lucas
    N Heerema
    M E Moran
    C Cheney
    D M Lucas
    L Wei
    M A Caligiuri
    J C Byrd
    Leukemia, 2009, 23 : 912 - 918
  • [42] A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma
    Woyach, J. A.
    Lin, T. S.
    Lucas, M. S.
    Heerema, N.
    Moran, M. E.
    Cheney, C.
    Lucas, D. M.
    Wei, L.
    Caligiuri, M. A.
    Byrd, J. C.
    LEUKEMIA, 2009, 23 (05) : 912 - 918
  • [43] A Phase 1/2 study evaluating the safety and efficacy of IOV-2001 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
    Long, Meixiao
    Woyach, Jennifer
    Pinilla-Ibarz, Javier
    Stephens, Deborah M.
    Cacovean, Alex
    Fiaz, Rana
    Goldberg, Zelanna
    Jagasia, Madan
    Finckenstein, Friedrich Graf
    Fardis, Maria
    Byrd, C.
    CANCER RESEARCH, 2021, 81 (13)
  • [44] Relevance of somatic hypermutation and interphase cytogenetics in lymphomatous presentation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Powers, M.
    Kreisel, F.
    Frater, J. L.
    Zehnbauer, B. A.
    Burack, R.
    Hassan, A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (04) : 696 - 696
  • [45] Update on a Phase 2 Study of Idelalisib in Combination with Rituximab in Treatment-Naive Patients ≥65 Years with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
    O'Brien, Susan
    Lamanna, Nicole
    Kipps, Thomas J.
    Flinn, Ian W.
    Zelenetz, Andrew D.
    Burger, Jan A.
    Holes, Leanne M.
    Cho, Yoonjin
    Dubowy, Ronald L.
    Coutre, Steven E.
    BLOOD, 2014, 124 (21)
  • [46] A PHASE 2 STUDY OF THE BTK INHIBITOR IBRUTINIB IN GENETIC RISK-STRATIFIED RELAPSED AND REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)
    Maddocks, K.
    Flynn, J. M.
    Andritsos, L. A.
    Awan, F.
    Woyach, J. A.
    Grever, M. R.
    Stefanos, M.
    Lynch, J.
    Johnson, A. J.
    Byrd, J. C.
    Jones, J. A.
    HAEMATOLOGICA, 2014, 99 : 522 - 522
  • [47] CD38 and CD138 expression in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Kampalath, B
    Novoa-Takara, L
    Rao, N
    Shidham, VB
    Chang, CC
    LABORATORY INVESTIGATION, 2003, 83 (01) : 238A - 238A
  • [48] Association of CD49d expression with small lymphocytic lymphoma (SLL) presentation of chronic lymphocytic leukemia (CLL).
    Strati, Paolo
    Chaffee, Kari G.
    Achenbach, Sara J.
    Slager, Susan L.
    Call, Timothy
    Kay, Neil E.
    Ding, Wei
    Parikh, Sameer Ashok
    Jelinek, Diane F.
    Hanson, Curtis A.
    Shanafelt, Tait D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Risk-Adapted Induction and Maintenance with Ofatumumab in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
    Ahn, Inhye
    Farooqui, Mohammed
    Lee, Yuh Shan
    Marti, Gerald
    Soto, Susan
    Tian, Xin
    Stetler-Stevenson, Maryalice
    Yuan, Constance M.
    Maric, Irina
    Wiestner, Adrian
    BLOOD, 2015, 126 (23)
  • [50] Plasmacytoid Differentiation in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Is Common and Enhanced in Proliferation Centers (PC)
    Moore, Erika
    Swerdlow, Steven
    Gibson, Sarah
    MODERN PATHOLOGY, 2015, 28 : 366A - 366A
12345